Electrostimulation System WoundEL for Leg Ulcers Healing (
NCT ID: NCT04980898
Last Updated: 2025-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
22 participants
INTERVENTIONAL
2021-03-16
2023-11-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Electrostimulation of wounds, including the WoundEL® device, is a therapy listed but not yet reimbursed in France. The aim of this study is to show that the WoundEL® electrostimulation device is superior to the reference treatments recognized by the HAS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers
NCT01022216
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
NCT00399308
Tissue Repair Gel in Venous Leg Ulcers (US)
NCT06707090
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
NCT01656889
Assessment of the Wound Healing Efficacy and Tolerance of a Medical Device on Wounds in Healthy Subjects.
NCT04687839
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The progress of the leg ulcer will be monitored every 2 weeks for 8 weeks or sooner if wound healing occurs. All leg ulcers will be examined at 10 weeks to check for healing or the condition of the leg ulcer if it has not healed. A third-blind party will also assess the ulcer condition at 10 weeks, based on standardized photographs.
The consumption of analgesics, pain and quality of life will be compared in the 2 groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Electrical stimulation wound management system
Two daily electrostimulation sessions using the WoundEL® device on wound two for 30 minutes at an adjustable intensity, between 5 and 42 milliampere and chosen by the patient.
WoundEL medical device
The WoundEl system is composed by: a class IIa device , a class IIb dressing electrode and a class I disperser electrode.
Applied to the leg ulcer, WoundEL® reproduces the endogenous electrical current to stimulate all the factors contributing to healing. Electrical current is evenly spread over the Dressing Electrode which also maintains a moist wound healing environment.
Standard cares
Cleaning and monitoring
Standard of care
Use of dressings appropriate to the stage of healing according to French recommendations for the management of leg ulcers.
Standard cares
Cleaning and monitoring
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WoundEL medical device
The WoundEl system is composed by: a class IIa device , a class IIb dressing electrode and a class I disperser electrode.
Applied to the leg ulcer, WoundEL® reproduces the endogenous electrical current to stimulate all the factors contributing to healing. Electrical current is evenly spread over the Dressing Electrode which also maintains a moist wound healing environment.
Standard cares
Cleaning and monitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a Systolic Pressure Index (IPS) at the ankle between 0.89 and 1.3 and / or a systolic pressure measurement at the big toe greater than or equal to 60 mmHg;
* Accept the port of venous compression;
* Presenting superficial and / or deep venous insufficiency, documented on a Doppler echo dating less than one year;
* affiliated to a social security scheme or beneficiary of such a scheme;
* Having given their free, informed and written consent.
Exclusion Criteria
* Cancerous ulcer;
* Treated with systemic corticosteroids or chemotherapy;
* for which a skin graft is necessary;
* Contraindications for the treatment of leg ulcers with the WoundEL system;
* Pregnant or lactating women;
* Vulnerable people or under legal/judicial protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
WoundEL Health Care
UNKNOWN
CEN Biotech
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
HERVE MAILLARD, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier du Mans
LAURE-CECILE MARTIN
Role: STUDY_DIRECTOR
WoundEL Health Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Du Mans
Le Mans, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C1633
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.